loader

World Tenders & Procurement Opportunities

802986- Czech Republic – Antineoplastic and immunomodulating agents – Monoclonal antibody - Daratumumab I.

World Biggest Tenders Source

This tender with title 802986- Czech Republic – Antineoplastic and immunomodulating agents – Monoclonal antibody - Daratumumab I. has been published on Bidding Source portal dated 09 Dec 2025 for the country of Czech Republic. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

802986- Czech Republic – Antineoplastic and immunomodulating agents – Monoclonal antibody - Daratumumab I.
Invitation for Bids
802986
Czech Republic
9 Dec 2025
8 Jan 2026
English
Antineoplastic and immunomodulating agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

57580- Czech Republic – Antineoplastic and immunomodulating agents – Drug supplies - csDMARD II. 2026 Czech Republic 58844- Czech Republic – Antineoplastic and immunomodulating agents – Medicinal products of ATC groups L04A* and L01XG03 Czech Republic Awarded - 41319- Czech Republic – Antineoplastic and immunomodulating agents – DYNAMIC PURCHASING SYSTEM FOR ONGOING AND REPEATED PURCHASES OF MEDICINAL PRODUCTS -- <b>Contract Value: 1 025 801 724,80 CZK</b> Czech Republic 844991-Awarded - Czech Republic – Antineoplastic and immunomodulating agents – Bacillus Calmette-Guérin -- <b>Contract Value: 5 585 112,00 CZK</b> Czech Republic 836316-Awarded - Czech Republic – Antineoplastic and immunomodulating agents – Drug supplies - csDMARD 2025 Czech Republic 824201- Czech Republic – Antineoplastic and immunomodulating agents – Medicinal product for autologous cell therapy - axikabtagen ciloleucel- 2025 Czech Republic 821311- Czech Republic – Antineoplastic and immunomodulating agents – Medicinal product for autologous cell therapy - brexukabtagen autoleucel - 2025 Czech Republic 815049- Czech Republic – Antineoplastic and immunomodulating agents – Drug supplies - csDMARD 2025 Czech Republic 815064-Awarded - Czech Republic – Antineoplastic and immunomodulating agents – Drug supplies - ROACTEMRA 2025 -- <b>Contract Value: 76 320 000,00 CZK</b> Czech Republic 797546-Awarded - Czech Republic – Antineoplastic and immunomodulating agents – Drug supplies – Active substance pegfilgrastim – ATC L03AA13 -- <b>Contract Value: 20 363 104,00 CZK</b> Czech Republic
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans